Tirzepatide is a synthetic peptide-based pharmaceutical compound that acts as a dual agonist of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. It is used in approved medical formulations for specific metabolic conditions, with indications and regulatory status varying by country.
Tirzepatide has been extensively studied for its effects on glucose regulation, appetite, and body-weight management. By activating both GIP and GLP-1 receptors, the compound influences several physiological pathways involved in insulin secretion and metabolic control.
For research or pharmaceutical documentation, the exact product specification should be verified against the manufacturer's official documentation and applicable regulatory standards.
